Hjem › Krampeanfald › North Carolina
Krampeanfald kliniske forsøg i North Carolina
11 studier for Krampeanfald søger deltagere på steder i North Carolina.
Byer i North Carolina
Officiel studietekst (engelsk)
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
- Atrium Health STRIVE Research, Charlotte
- On-Site Clinical Solution, Charlotte
- Duke University Medical Center, Durham
- og 1 flere
RekruttererFase 3
Alder 2 til 55 · Alle køn · Opdateret 2. okt. 2026 · NCT05066217A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
- Onsite Clinical Solutions, Charlotte
- Velocity Clinical Research at Raleigh Neurology, Raleigh
RekruttererFase 1
Alder 12 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT07233239RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
- Asheville Neurology Specialists, Asheville
- OnSite Clinical Solutions, LLC, Charlotte
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 1. okt. 2026 · NCT06798896Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
- Asheville Neurology Specialists, Asheville
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 1. okt. 2026 · NCT07563881A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
- Duke University Health System, Durham
- Science 37, Morrisville
- Wake Forest Baptist Medical Center, Winston-Salem
RekruttererFase 3
Alder 2 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT04462770Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
- Velocity Clinical Research, Raleigh
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 2. sep. 2026 · NCT07594119Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- Atrium Health, Charlotte
- Duke University Hospital, Durham
- Atrium Wake Forest Baptist, Winston-Salem
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 9. jun. 2026 · NCT05135091A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Duke University Clinic, Durham
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 14. maj 2026 · NCT05716100Oxygen Toxicity: Mechanisms in Humans
- Duke University Health Sustem, Durham
RekruttererFrivillige med god helbredstilstand velkomne
Alder 18 til 45 · Alle køn · Opdateret 23. okt. 2025 · NCT05761756Pediatric Dose Optimization for Seizures in Emergency Medical Services
- Mecklenburg EMS, Charlotte
RekruttererFase 3
6 Months – 13 Years · Alle køn · Opdateret 30. sep. 2025 · NCT05121324Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- Duke University Clinical Research at Pickett Road, Durham
RekruttererFase 3
Alder 4 til 55 · Alle køn · Opdateret 24. jul. 2025 · NCT05219617Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.